QM
QMS Medical Allied Services Ltd (QMSMEDI)
₹170.00
Mkt cap
₹329 Cr
P/E ratio
32.90
P/B
3.62
Div yield
0.29%
ROE
10.40%
ROCE
12.90%
EPS (TTM)
₹5.17
Book value
₹47
52W range
69–217
Sector
Healthcare
Price history
Previous close
Incorporated in 2017, QMS Medical Allied Services Ltd is a manufacturer and distributor of medical devices [1]
NSE QMSMEDI
Health check
Constructive
ValuationFair
ProfitabilityAverage
GrowthHigh
52-week range
₹170
₹69₹217
Current
₹170.00
Prev close
—
Day
—
Financials
Revenue, profit & margin
P/E ratio
32.9×
QMSMEDI is 11% below the sector median of 36.9×
QMSMEDI32.9×
Sector median36.9×
| Sep 2023 (S) | Dec 2023 | Mar 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 28.64 | 35.24 | 32.29 | 37.20 | 43.87 | 44.58 | 46.50 | 44.70 | 37.26 | 44.42 | 56.87 | 52.52 | |
| YoY Sales growth | +4.30% | +24.49% | +38.06% | +20.16% | -15.07% | -0.36% | +22.30% | +17.49% | |||||
| Expenses | 23.74 | 30.40 | 28.34 | 29.96 | 36.93 | 38.21 | 39.96 | 37.78 | 30.51 | 38.50 | 48.56 | 46.00 | |
| Operating Profit | 4.90 | 4.84 | 3.95 | 7.24 | 6.94 | 6.37 | 6.54 | 6.92 | 6.75 | 5.92 | 8.31 | 6.52 | |
| OPM % | 17.11% | 13.73% | 12.23% | 19.46% | 15.82% | 14.29% | 14.06% | 15.48% | 18.12% | 13.33% | 14.61% | 12.41% | |
| Other Income | 0.11 | 0.15 | 0.11 | 0.33 | 0.19 | 1.09 | 0.32 | 0.22 | 0.30 | 0.22 | 0.42 | 0.22 | |
| Interest | 0.74 | 0.81 | 0.99 | 1.07 | 1.31 | 1.41 | 1.44 | 1.36 | 1.75 | 2.08 | 1.71 | 1.86 | |
| Depreciation | 0.86 | 0.88 | 0.88 | 0.84 | 0.86 | 1.36 | 0.93 | 0.94 | 1.02 | 1.39 | 1.47 | 1.60 | |
| Profit before tax | 3.41 | 3.30 | 2.19 | 5.66 | 4.96 | 4.69 | 4.49 | 4.84 | 4.28 | 2.67 | 5.55 | 3.28 | |
| Tax % | 25.22% | 25.76% | 29.68% | 25.27% | 30.24% | 23.24% | 29.62% | 26.24% | 25.70% | 29.21% | 28.65% | 25.61% | |
| Net Profit | 2.56 | 2.44 | 1.54 | 4.23 | 3.47 | 3.60 | 3.16 | 3.58 | 3.17 | 1.88 | 3.96 | 2.44 | |
| EPS in Rs | 1.41 | 1.35 | 0.85 | 1.90 | 1.61 | 1.85 | 1.62 | 1.61 | 1.24 | 0.82 | 1.89 | 1.22 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move +4.71% · closed higher next day 1 of last 1
| Q1FY27 | |
|---|---|
| Broadcast | 14 Aug '26◦ |
| Earnings day | +4.71% |
| +1 day | +2.52% |
| +5 days | +10.82% |
| +15 days | +22.70% |
| +30 days | +64.33% |
| Filing | XBRL |
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Results analysis
Shareholding
as of Sep 202668.11%Promoter
Promoters68.11%
FIIs0.41%0.41
DIIs1.30%0.29
Public30.17%0.13
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Molbio Diagnosti | ₹1,495.50 | 237.56 | 17,226 | 0.00% | 8 | −86.23% | 259 | −55.36% | 18.48% |
| Poly Medicure | ₹1,635.70 | 52.52 | 16,600 | 0.21% | 95 | −4.31% | 581 | +30.79% | 12.50% |
| Sahajanand Medi | ₹527.60 | 74.56 | 5,354 | 0.00% | 26 | +32.12% | 373 | +24.69% | 11.35% |
| Tarsons Products | ₹303.40 | 195.16 | 1,596 | 0.00% | 0 | −110.24% | 124 | +20.83% | 4.59% |
| Fischer Medical | ₹22.33 | 137.04 | 1,559 | 0.22% | 1 | −94.22% | 107 | +24.50% | 11.45% |
| Laxmi Dental | ₹187.57 | 28.50 | 1,034 | 0.00% | 10 | +17.58% | 80 | +10.03% | 15.05% |
| Q-Line Biotech | ₹396.80 | 16.91 | 926 | 0.00% | 20 | −8.07% | 152 | +5.83% | 22.45% |
| QMS Medical | ₹170.03 | 32.91 | 329 | 0.29% | 2 | −24.36% | 53 | +17.49% | 12.92% |
| Median: 18 Co. | ₹302.90 | 36.92 | 664 | 0.00% | 5 | −6.19% | 83 | +17.91% | 15.05% |
Filings
Concall transcripts23
PPTNov 2026RECNov 2026TranscriptAug 2026PPTAug 2026RECAug 2026PPTAug 2026TranscriptJun 2026PPTFeb 2026TranscriptNov 2025PPTNov 2025TranscriptAug 2025TranscriptNov 2024PPTNov 2024TranscriptAug 2024PPTAug 2024TranscriptMay 2024PPTMay 2024TranscriptFeb 2024PPTFeb 2024TranscriptNov 2023PPTNov 2023TranscriptSep 2023PPTSep 2023
Announcements5
Analysts/Institutional Investor Meet/Con. Call Updates 17 Nov - Audio recording uploaded for Q2 and half-year FY2027 earnings call held on November 17, 2026.Investor Presentation 17 Nov - Investor presentation covers Q2/H1 FY27 results, merger of PSP businesses, and BeamOptics acquisition plans.Copy of Newspaper Publication 16 Nov - Published unaudited standalone and consolidated results for quarter and half year ended 30 September 2026.Outcome of Board Meeting 14 Nov - Board approved Q2/H1 FY2027 standalone and consolidated unaudited results on November 14, 2026.Analysts/Institutional Investor Meet/Con. Call Updates 12 Nov - Q2 and H1 FY27 earnings conference call scheduled for 17 November 2026 at 11:30 AM IST.
